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Abstract
There have only been a few randomized controlled trials of surgical treatment of chronic low back
pain caused by degenerative disc disease. Fusion surgery has been compared primarily with
nonoperative treatment, whereas disc arthroplasty has been compared with fusion surgery. The
results for either of the two surgical procedures are modest in terms of pain relief and improved
function.
Introduction and context
Surgical procedures are quite commonly used as a
treatment for chronic lowback pain assumedto originate
from the intervertebral disc. Although there are a large
number of outcome studies, only a few randomized
controlled trials have been performed. Randomized
controlled trials are important since they offer the
strongest evidence for treatment effect. Randomization
reduces biases from known and unknown confounders,
and typically (but not always), randomized trials are
more rigorous in their collection of data and in
measuring outcomes and reporting them. Because it is
difficult to conduct placebo-controlled trials of surgical
procedures and difficult to conduct sham trials, most
studies compare surgery with nonoperative care or one
surgical procedure with another. Surgery and nonopera-
tive care are often treated as ‘black boxes’, that is, they are
treated without regard to variations in technique and
skills, and adaptations to different patients. Additionally,
the risk of undertreatment in the comparison group can
occur, and - not infrequently - there may be variation in
cotreatment between groups. Problems also arise follow-
ing crossover between treatment groups, as this tends to
systematically reduce differences in outcomes between
control and experimental subjects, reducing the value of
randomization. The preferred statistical analysis is an
intention-to-treat analysis, in which outcomes are
analysed based on the assigned treatment arm. Although
this does preserve the value of randomization, it raises
the question of whether it is appropriate to consider a
patient surgical if he or she actually did not have a
surgical procedure.
Recent advances
Three randomized controlled trials of fusion for low back
pain and two controlled trials of disc arthroplasty have
been published in recent years. These studies provide
data that allow an appraisal of how effective surgery is for
the treatment of chronic low back pain.
The study of Fritzell and colleagues [1] showed that
fusion was more effective than conservative care. The
study of Brox and colleagues [2] found fusion to be no
more effective than cognitive therapy and exercises. The
study of Fairbank and colleagues [3] found fusion to be
minimally more effective than a rehabilitation program.
Improvements in Oswestry Disability Index (ODI) were
from 47.3 to 35.7 in the Fritzell study, from 42 to 26 in
the Brox study, and from 46.5 to 34 in the Fairbank
study.
As pointed out by Mirza and Deyo [4], the mean
improvements in ODI achieved in two of these studies
[1,3] were less than the threshold of 15 points that the
US Food and Drug Administration considers to be the
minimal clinically important change (MCIC). The Brox
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Fritzell study, only 29% of patients rated themselves as
‘much better’. No patient was reported as having been
rendered free of pain. The other two studies did not
report this outcome. The Fairbank study reported a
change in mean scores for bodily pain from 28.6 to 48.1.
In the Brox study, pain scores improved by 20 points
(from 60 to 40), which barely equals the MCIC for back
pain.
Blumenthal et al. [5] compared disc arthroplasty, using a
particular device, with a form of anterior lumbar
interbody fusion. Zigler et al. [6] compared arthroplasty,
using a different device, with circumferential fusion.
Although the Blumenthal study found disc arthroplasty
to be not inferior to fusion, the outcomes of arthroplasty
were modest. Mean pain scores improved by 40 points
(from 70 to 30), which exceeds the MCIC of 20 points,
and ODI improved from 50 to 25. But 64% of patients
treated by surgery still took opioids, and although 64%
returned to work, 53% had been working before surgery.
These latter figures do not attest to any decrease in the
burden of illness; surgery did not seem to alter the
patients’ use of other health care services, or their ability
to work.
The Zigler study found disc arthroplasty to be slightly
more effective, on average, than circumferential fusion,
but it too reported only modest results for both surgical
treatments. For arthroplasty, ODI improved from 63.4
at inception to 34.5 at 24 months, but with a standard
deviation of 24.8. This latter figure indicates that a
substantial proportion of patients were still substantially
disabled. Pain scores improved from just above 70 to
37, with a standard deviation of 30.1. This study judged
outcomes as a success if the ODI improved by 15 points.
On this basis, a 72% success rate was claimed. But this
misrepresents MCIC. The MCIC does not amount to the
least value at which success occurs. It is no more than
the least value that patients equate with a detectable
level of improvement. The study did not report the
proportion of patients rendered substantially better or
free of pain. Of patients considered to have a successful
outcome, 39% still took opioids, which seems
contradictory.
These results from controlled trials of arthroplasty are
starkly inferior to those of a well-reported descriptive
study. In the study of Bertagnoli et al. [7], mean pain
scores improved from 7.5 to 3 and ODI improved from
54 to 29. At 2 years, 32% of patients had no back pain,
59% had only occasional pain, 90% took no opioids,
and only 41% required nonsteroidal anti-inflammatory
drugs for pain.
Implications for clinical practice
Surgeons and others believe that surgery is effective for
back pain. They base this belief either on their own
experience or on observational studies. This belief is, by
and large, not vindicated by the outcomes in well-
reported clinical trials. Those trials indicate that only a
small proportion of patients do well from surgery. If
surgeons achieve better outcomes than those reported in
the controlled trial literature, the community would
benefit from the publication of those outcomes. In the
absence of contradicting evidence, the benefits of surgery
must be regarded as small. Because improvements from
surgery are small and because not all patients benefit, it
becomes critically important to carefully select patients
in whom fusion surgery is performed for chronic back
pain. Furthermore, it is important that patients have a
clear understanding of the procedure and its potential
results and complications so that they can participate in
the decision.
Differences in results from one study to another may be
explained by the selection of patients, but the surgical
procedure itself and its performance are likely to
influence outcomes as well. In an editorial, Fritzell [8]
posed the question: ‘is surgical treatment consistent with
evidence-based medicine?’, and answered it with: ‘yes, in
selected patients’. But surgeons have not yet articulated
the definition of the correctly selected patient, and tested
it prospectively. The reputation of surgery rests on the
observation, after treatment, that some patients some-
times do well, with some procedures. That is little solace
to the majority of patients who do not do well, who
suffer complications, or who are rendered worse by
surgery.
Abbreviations
MCIC, minimal clinically important change; ODI,
Oswestry Disability Index.
Competing interests
The authors declare that they have no competing
interests.
References
1. Fritzell P, Hägg O, Wessberg P, Nordwall A; Swedish Lumbar Spine
Study Group: 2001 Volvo Award Winner in Clinical Studies:
Lumbar fusion versus nonsurgical treatment for chronic low
back pain: a multicenter randomized controlled trial from
the Swedish Lumbar Spine Study Group. Spine 2001, 26:2521-
32.
2. Brox JI, Sørensen R, Friis A, Nygaard Ø, Indahl A, Keller A,
Ingebrigtsen T, Eriksen HR, Holm I, Koller AK, Riise R, Reikerås O:
Randomized clinical trial of lumbar instrumented fusion and
cognitive intervention and exercises in patients with chronic
low back pain, and disc degeneration. Spine 2003, 28:1913-21.
3. Fairbank J, Frost H, Wilson-MacDonald J, Yu LM, Barker K, Collins R;
Spine Stabilisation Trial Group: Randomised controlled trial to
Page 2 of 3
(page number not for citation purposes)
F1000 Medicine Reports 2009, 1:60 http://F1000.com/Reports/Medicine/content/1/60compare surgical stabilisation of the lumbar spine with an
intensive rehabilitation programme for patients with chronic
low back pain: the MRC spine stabilisation trial. BMJ 2005,
330:1233.
4. Mirza SK, Deyo RA: Systematic review of randomized trials
comparing lumbar fusion surgery to nonoperative care for
treatment of chronic back pain. Spine 2007, 32:816-23.
5. Blumenthal S, McAfee PC, Guyer RD, Hochschuler SH, Geisler FH,
Holt RT, Garcia RJr, Regan JJ, Ohnmeiss DD: A prospective,
randomized, multicenter Food and Drug Administration
investigational device exemptions study of lumbar total disc
replacement with the CHARITE artificial disc versus lumbar
fusion: part I: evaluation of clinical outcomes. Spine 2005,
30:1565-75.
Changes Clinical Practice
F1000 Factor 3.0 Recommended
Evaluated by Constantin Schizas 07 Feb 2006
6. Zigler J, Delamarter R, Spivak JM, Linovitz RJ, Danielson GO 3rd,
Haider TT, Cammisa F, Zuchermann J, Balderston R, Kitchel S,
Foley K, Watkins R, Bradford D, Yue J, Yuan H, Herkowitz H,
Geiger D, Bendo J, Peppers T, Sachs B, Girardi F, Kropf M, Goldstein J:
Results of the prospective, randomized, multicenter Food
and Drug Administration investigational device exemption
study of the ProDisc-L total disc replacement versus
circumferential fusion for the treatment of 1-level degen-
erative disc disease. Spine 2007, 32:1155-62.
7. Bertagnoli R, Yue JJ, Shah RV, Nanieva R, Pfeiffer F, Fenk-Mayer A,
Kershaw T, Husted DS: The treatment of disabling single-level
lumbar discogenic low back pain with total disc arthroplasty
utlilizing the Prodisc prosthesis. A prospective study with
2-year minimum follow-up. Spine 2005, 30:2230-6.
8. Fritzell P: Fusion as treatment for chronic low back pain -
existing evidence, the scientific frontier and research strate-
gies. Eur Spine J 2005, 14:519-20.
Page 3 of 3
(page number not for citation purposes)
F1000 Medicine Reports 2009, 1:60 http://F1000.com/Reports/Medicine/content/1/60